-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

311.P1.62 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I

Symposia: Disorders of Platelet Number or Function: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Amaury Monard, MD1*, Floris Van Dellen2*, Dave Hellenbrand3*, Paul Verhezen4*, Erik AM Beckers, MD, PhD5, Yvonne Henskens6,7* and Floor CJI Moenen, MD, PhD8*

1Maastricht University, CARIM - School for cardiovascular disease, Maastricht, New Zealand
2Internal Medicine - Hematology, Maastricht University Medical Center + (MUMC+), Maastricht, Netherlands
3Central Diagnostic Laboratory, Maastricht University Medical Center + (MUMC+), Maastricht, Netherlands
4Central Diagnostic Laboratory, Maastricht University Medical Center + (MUMC+), Maastricht, NLD
5Maastricht University Medical Center, Maastricht, NLD
6CARIM - School for cardiovascular disease, Maastricht, Netherlands
7Maastricht UMC+, Maastricht, NLD
8Department of Internal Medicine, Hematology, Maastricht University Medical Center+ and Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Maastricht, Netherlands

Haiyu Zhang, PhD1*, Henning Stehr, PhD1*, Robert D Bona, MD2, Jean M. M Connors, MD3, William Shomali, MD4, Jason Gotlib, MD4*, James B. Bussel, MD5 and James L. Zehnder, MD1

1Department of Pathology, Stanford University, Stanford, CA
2Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Harvard Medical School, Brigham and Women's Hospital, Boston, MA
4Division of Hematology, Stanford Cancer Institute/ Stanford University School of Medicine, Stanford, CA
5Department of Pediatrics, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY

Eleanore A. McFarland, BS1*, Margaret H. McKelvy2*, Katherine A. Knightly, BSc3*, Stephanie V. Volpe4*, Thea D. Palmer, BA4*, Stacy Corke4*, Emilie Vander Haar, MD3* and James B. Bussel, MD5

1Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York City, NY
2Renaissance School of Medicine at Stony Brook University, New York, NY
3Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY
4NAITbabies, Penzance, United Kingdom
5Department of Pediatrics, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY

Sovijja Pou, MD1*, Charmi Trivedi, MD1*, Charles Milrod, MD2, Christina Raker, ScD3* and Andrew Hsu, MD4

1Department of Internal Medicine, Rhode Island Hospital, Providence, RI
2Department of Hematology/Oncology, Brown University, Providence, RI
3Biostatistics, Epidemiology, and Research Design, Rhode Island Hospital, Providence, RI
4Department of Hematology/Oncology, Rhode Island Hospital, Providence, RI

Katherine A. Knightly, BSc1*, Margaret H. McKelvy2*, James B. Bussel, MD3, Emilie Vander Haar, MD4*, Eleanore A. McFarland, BS5*, Thea D. Palmer, BA6*, Stephanie V. Volpe7* and Stacy Corke7*

1Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY
2Renaissance School of Medicine at Stony Brook University, New York, NY
3Department of Pediatrics, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY
4Weill Cornell Medicine, New York, NY
5Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York City, NY
6NAIT Babies, Penzance, United Kingdom
7NAITbabies, Penzance, United Kingdom

Madhavi Lakkaraja, MD, MPH1,2, Emilie Vander Haar, MD3*, Eleanore A. McFarland, BS4*, Katherine A. Knightly, BSc3* and James B. Bussel, MD3,5

1University of Washington School of Medicine, Fred Hutchinson Cancer Center, Seattle, WA
2Department of Pediatrics, Division of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA
3Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY
4Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York City, NY
5Department of Pediatrics, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY

Andrew B Song, MD1,2, Brian Curtis, PhD, D(ABMLI), MT (ASCP) SBB3 and Hanny Al-Samkari, MD2,4

1Division of Hematology, Massachusetts General Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Platelet and Neutrophil Immunology and Hematology Genetics Labs, Versiti, Milwaukee, WI
4Division of Hematology, Massachusetts General Hospital, Cambridge, MA

Assaf Barg1*, Adina Lashansky2*, Amos Toren, MD3*, Gili Kenet, MD4 and Hana Golan2*

1Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel
2Tel Aviv University, Tel Aviv, Israel
3sheba medical center, Tel Aviv University, Tel Aviv, Israel
4Chaim Sheba Medical Center, Tel Hashomer, ISR

Bianca Clerici1,2*, Mariangela Scavone1*, Carlo Urtis1*, Giuseppina Vismara2*, Sara Vavassori2*, Andrea Luigi Crosignani2*, Sara De Matteis1,2*, Pier Maria Battezzati1,2*, Simone Birocchi2*, Marco Natale Cattaneo3* and Gian Marco Podda1,2*

1University of Milan, Milan, Italy
2Ospedale San Paolo, ASST Santi Paolo e Carlo, Milan, Italy
3Fondazione Arianna Anticoagulazione, Bologna, Italy

Maria Eva Mingot-Castellano, MD, PhD1*, Beatriz Chiclana Rodriguez1*, Blanca Sánchez-González2,3*, Daniel Martinez Carballeira4*, Mariana Canaro Hinryk, MD5*, Isabel Caparros Miranda6*, Denis Zafra7*, Aída Calo Pérez8*, Maria Cristina Pascual Izquierdo, MD, PhD9*, Gonzalo Caballero Navarro10*, Marta Canet Maldonado11*, Maria Carmen Gómez del Castillo Solano12*, Amalia Cuesta Garcia13*, Patricia Alcalde Mellado, MD1*, Marta García Culebra1*, Francesc Garcia-Pallarols, BSc14*, Lola Piquer Monsonis15*, Paula Sanchez Llorca16*, Diana Casares17*, Rocio Perez Montes13*, David Valcarcel, MD, PhD18 and Begoña Pedrote Amador, MD1*

1Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla. Universidad de Sevilla, Sevilla, Spain
2Hospital del Mar Research Institute, Barcelona, Spain
3Hematology Department, Hospital del Mar, Barcelona, Spain
4Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain, Oviedo, Spain
5Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
6Hospital Universitario Virgen de la Victoria, Málaga., Malaga, Spain
7Hospital Universitario 12 De Octubre, Madrid, Spain
8Hospital de Henares, Coslada, Spain
9Servicio de Hematología, Hospital Universitario Gregorio Marañón, Instituto de Investigación Gregorio Marañón, Madrid, Madrid, Spain
10Hematology Department. Hospital Miguel Servet, Zaragoza, Spain., Zaragoza, ESP
11Hospital Universitari Mútua Terrassa, Terrassa, Barcelona., Barcelona, Spain
12Complexo Hospitalario Universitario A Coruña, La Coruña, Spain
13Hospital de Sierrallana, Torrelavega, Spain
14Hospital del Mar, Barcelona, Spain
15Hospital Universitario Son Espases, Mallorca, Spain
16Hospital 12 de octubre, Madrid, Spain
17Hospital Universitario Gregorio Marañon, Madrid, Spain
18Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Sailaja Vinnakota1, Ronak H. Mistry, DO2, Rebecca Pesce-Noga, MS, CSSBB3*, Maria Rybacka, MBBS4*, Stefan Radevic, MBBS5*, Carrie Marvill6* and Patricia A. Locantore-Ford, MD7

1Department of Medicine, Pennsylvania Hospital, Philadelphia, PA
2Division of Hematology/Oncology, Department of Medicine, Hospital of University of Pennsylvania, Philadelphia, PA
3Department of Hematology/Oncology, Pennsylvania Hospital, Philadelphia, PA
4Royal College of Surgeons in Ireland, Dublin, AL, IRL
5Royal College of Surgeons in Ireland, Dublin, Ireland
6Abramson Cancer Center- Pennsylvania Hospital, Philadelphia
7Division of Hematology/Oncology, Department of Medicine, Pennsylvania Hospital, Philadelphia, PA

Huiying Zhi, MD & PhD1, Douglas Sheridan, PhD2*, Peter J. Newman, PhD3 and Debra K. Newman, PhD3

1Blood Research Institute, Versiti, Milwaukee, WI
2Rallybio,, New Haven, CT
3Blood Research Institute, Versiti BloodCenter of Wisconsin, Milwaukee, WI

Taylor Olmsted Kim, MD1,2, Kirsty Hillier, MD3, Elizabeth Gunn, MD4, Sherif M. Badawy, MD, MS, MBA5,6, Amanda B. Grimes, MD7,8, Megan Gilbert, MD, MS9*, Allison Remiker, MD10*, Stephanie A. Fritch Lilla, MD11, Shipra Kaicker, MD12, Michele P. Lambert, MD13,14, Rachael F. Grace, MD, MMSc15,16 and Deirdra R Terrell, PhD17

1University of Southern California, Keck School of Medicine, Los Angeles, CA
2University of Southern California Keck School of Medicine, Children's Hospital Los Angeles, Pasadena, CA
3Hassenfeld Children's Hospital at NYU Langone Health, New York, NY
4Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University, Atlanta, GA
5Division of Hematology, Oncology, Neuro-Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, IL
6Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL
7Texas Children’s Cancer and Hematology Center, Houston, TX
8Baylor College of Medicine, Houston, TX
9Lucile Packard Children's Hospital Stanford, Palo Alto, CA
10Medical College of Wisconsin, Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Pewaukee, WI
11Children's Minnesota, Minneapolis, MN
12Department of Pediatric Hematology Oncology, Weill Cornell Medicine/New York Presbyterian-Weill Cornell Medical College, New York, NY
13Children's Hospital of Philadelphia, Philadelphia, PA
14Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
15Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
16Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
17University of Oklahoma Health Sciences Ctr, Oklahoma City, OK

Yimei Feng1*, Hanqing Zeng2*, Yi Liao3*, Yi Yang4*, Wenzheng Yu5*, Changyong Yuan6*, Guojun Li7*, Zhanshu Liu, MD8*, Huae Shu9*, Guoxiang Zhang10*, Yaqing Feng11*, Chunfang Peng12*, Xiaoli Chen13*, Jia Liu14*, Han Yao13,15*, Ming Hou16* and Xi Zhang, PhD17

1Army medical University affiliated Xinqiao Hospital, Chongqing, China
2Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, CHN
3Department of Hematology, Chongqing Emergency Medical Center, Chongqing, China
4Department of Hematology, Congqing University Three Gorges Hospital, Chongqing, China
5Department of Hematology, Binzhou Medical University Hospital, Binzhou, China
6Dezhou People's Hospital (Shandong University Qilu Hospital Dezhou Hospital), Dezhou City, China
7Department of Hematology, Chongqing Hechuan District People's Hospital, Chongqing, China
8Department of Hematology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China
9Department of Hematology and Rheumatology, Chongqing Kaizhou District People's Hospital, Chongqing, CHN
10Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China
11Department of Hematology, The Third People's Hospital of Datong,, Datong, China
12Department of oncology, Chongqing University Jiangjin Hospital, Chongqing, China
13Xinqiao Hospital, Army Medical University, Chongqing, China
14The Second Affiliated Hospital of Army Military Medical University, Chongqing, China
15Xinqiao Hospital, Chongqing, China
16Qilu Hospital of Shandong University, Jinan, China
17Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China

Jing Wu1*, Jieping Li2*, Chaoyu Wang2*, Dehong Huang2*, Bingling Guo2* and Yao Liu1

1Chongqing University Cancer Hospital, Chongqing, China
2Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China

Emily M Harris, MD1,2 and Rachael F. Grace, MD, MMSc1,2

1Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
2Harvard Medical School, Boston, MA

Kai Fan, Ph.D, MD*, Qing Chen, M.Sc*, Shehui Hu*, Xin Zeng*, Xiaolan Qin* and Jing Sun, M.Sc*

Chongqing Peg-Bio BioPharm.Co.,Ltd., Chongqing, China

Rachael F. Grace, MD, MMSc1, Goksel Leblebisatan, MD2*, Yesim Aydinok, MD3*, Sule Unal4*, John D. Grainger, MD, MRCP, FRPATH5*, Jessica Zhang, MS6*, Brian Jamieson6 and Scott Kolodny, MD6*

1Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
2Department of Pediatric Hematology, Çukurova University Medical Faculty, Adana, Turkey
3Department of Pediatric Hematology and Oncology, Ege University School of Medicine, Izmir, Turkey
4Department of Pediatric Hematology, Hacettepe University Faculty of Medicine, Ankara, Turkey
5Royal Manchester Children's Hospital, Pendlebury, GBR
6Sobi Inc., Waltham, MA

Bingling Guo1*, Jieping Li1* and Yao Liu2

1Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China
2Chongqing University Cancer Hospital, Chongqing, China

Chunyan Xiao1*, Yao Ding1*, Chensi Zeng1*, Lingqian Zhang1*, Jing Wu2*, Yingyu Nan1* and Yao Liu2

1Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China
2Chongqing University Cancer Hospital, Chongqing, China

James B. Bussel, MD1,2, Pamela Baker, PharmD3*, Edwin Lam3*, Paige Meizlik3*, Hein Fennema3*, Rebecca Zaha3*, Hillary Van Valkenburgh3* and Kattayoun Kordy3*

1Department of Pediatrics, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY
2New York Presbyterian Hospital, New York
3Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House

*signifies non-member of ASH